Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (263)
- Legislation (86)
- COVID-19 (66)
- Compliance and enforcement (56)
- Vaping hub (48)
- Manufacturing (31)
- Import and export (24)
- Labelling and packaging (21)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (19)
- Safety monitoring and information (15)
- Weight loss products (7)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Committees and advisory bodies (2)
- Prescription opioids hub (2)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (2)
- Clinical trials (1)
- Fees and payments (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
720 result(s) found, displaying 526 to 550
-
Media releasesThe TGA has initiated proceedings in the Federal Court of Australia in response to the alleged unlawful advertising of Miracle Mineral Supplement (MMS), dimethyl sulfoxide (DMSO) and other medicines by Southern Cross Directories Pty Ltd trading as MMS Australia
-
Media releasesThe TGA is reminding advertisers that therapeutic goods advertising must not undermine public health campaigns, as the cold and flu season begins in Australia and COVID-19 restrictions are eased
-
Media releasesThe TGA has issued four infringement notices totalling $50,400 to Brisbane based company Allpulse Technologies Pty Ltd
-
Media releasesThe TGA has issued a $12,600 infringement notice to Melbourne based company NutriPATH Pty Ltd for the alleged unlawful advertising of a COVID-19 Polymerase Chain Reaction (PCR) test collection kit.
-
Media releasesThe TGA has issued fifteen infringement notices totalling $37,800 to a doctor in Perth
-
Media releasesThe TGA has issued twelve infringement notices totalling $151,200 for the alleged unlawful advertising of Miracle Mineral Supplement and other medicines
-
Media releasesFrom 1 July 2020, medicine advertisements in specified media do not need pre-approval from the TGA
-
Media releasesThe TGA has issued an infringement notice for $2,520 to a woman in Western Australia for alleged breaches relating to COVID-19 test kits
-
Media releasesThe TGA has issued five infringement notices totalling $63,000 to a Queensland company for alleged breaches relating to COVID-19 test kits
-
Regulatory decision noticesInformation on an exemption for radiopharmaceuticals that facilitates interstate supply during COVID-19
-
Media releasesTo improve access to important ingredient information, TGA publishes the names of excipients in medicines and biologicals on its website
-
Media releasesThe TGA has issued two infringement notices to Peter Evans' company totalling $25,200 for alleged breaches of therapeutic goods legislation in relation to the promotion of a 'BioCharger' device
-
Media releasesThe TGA has issued infringement notices totalling $25,200 to Queensland company CK Surgitech for alleged breaches relating to COVID-19 test kits
-
Media releasesThe TGA has issued an infringement notice for $2,520 to a woman in Western Australia for alleged breaches relating to COVID-19 test kits
-
Media releasesThe TGA has issued an infringement notice for $12,600 to Labtest Direct for the alleged advertising of COVID-19 Rapid Test kits
-
Media releasesThe Federal Court granted the interim injunction on 3 April 2020
-
Media releasesThe TGA has issued ATP Science Pty Ltd with 24 infringement notices
-
Media releasesThe TGA has issued Oxymed Australia Pty Ltd five infringement notices for alleged advertising breaches
-
Media releasesThe TGA will take action in relation to the illegal advertising of therapeutic goods, including those that make false and misleading claims about preventing or curing COVID-19
-
Media releasesDue to changes in travel restrictions, all overseas GMP inspections and QMS audits have now been suspended until further notice
-
Media releasesCommunity pharmacists to enforce new limits on dispensing and sales of prescription and over-the-counter medicines
-
-
Media releasesStockpiling medicines may disrupt access to vital medicines by patients and pharmacies
-
Media releasesThe Secretary of the Department of Health has commenced proceedings in the Federal Court of Australia (Court) against Evolution Supplements Australia Pty Ltd
-
Regulatory decision noticesListed medicine ingredients and requirements have been updated.